澳华内镜股价跌5.04%，天弘基金旗下1只基金重仓，持有4.84万股浮亏损失11.28万元

Company Overview - Aohua Endoscopy is located in Minhang District, Shanghai, and was established on October 27, 1994. The company went public on November 15, 2021. It specializes in the research, production, and sales of electronic endoscopy equipment and related medical consumables [1] - The main revenue composition of Aohua Endoscopy includes: 92.35% from endoscopy equipment, 3.71% from endoscopic diagnostic consumables, 3.58% from endoscopy maintenance services, and 0.35% from leasing income [1] Stock Performance - On February 2, Aohua Endoscopy's stock fell by 5.04%, trading at 43.94 CNY per share, with a total transaction volume of 97.43 million CNY and a turnover rate of 1.60%. The total market capitalization is 5.917 billion CNY [1] Fund Holdings - Tianhong Fund has a significant holding in Aohua Endoscopy through its Tianhong Zhenxuan Health Mixed A fund (014708), which reduced its holdings by 20,100 shares in the fourth quarter, now holding 48,400 shares, accounting for 7.82% of the fund's net value [2] - The estimated floating loss for the fund today is approximately 112,800 CNY [2] Fund Performance - Tianhong Zhenxuan Health Mixed A fund was established on March 17, 2022, with a current size of 18.2122 million CNY. Year-to-date returns are 6.22%, ranking 3720 out of 9000 in its category. Over the past year, the fund has achieved a return of 38.85%, ranking 3199 out of 8193. Since inception, the fund has returned 24.87% [2]